OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA

CompletedOBSERVATIONAL
Enrollment

733

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Diabetes Mellitus, Non-Insulin-Dependent
Trial Locations (20)

Unknown

Research Site, Blagoevgrad

Research Site, Pleven

Research Site, Plovdiv

Research Site, Sofia

Research Site, Alexandria

Research Site, Brasov

Research Site, Bucharest

Research Site, Cluj-Napoca

Research Site, Constanța

Research Site, Craiova

Research Site, Galati

Research Site, Giurgiu

Research Site, Iași

Research Site, Oradea

Research Site, Piteşti

Research Site, Ploieşti

Research Site, Satu Mare

Research Site, Tg Jiu

Research Site, Tg Mures

Research Site, Timișoara

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY